BEUDAMED
    FDA Enforcement Class II Terminated

    HDL-Cholesterol gen.3. For the quantitative determination of high-density lipoprotein Cholesterol (HDL-C) in serum and plasma.

    Recall: Z-1924-2015 · Reported July 8, 2015

    Enforcement

    Recall Number
    Z-1924-2015
    Event ID
    71182
    Classification
    Class II
    Status
    Terminated
    Product Type
    Devices
    Firm
    Roche Diagnostics Operations, Inc.
    Voluntary / Mandated
    Voluntary: Firm initiated
    Initial Notification
    Letter
    Report Date
    July 8, 2015
    Initiation Date
    May 7, 2015
    Classification Date
    June 27, 2015
    Termination Date
    March 24, 2017
    Address
    9115 Hague Rd, Indianapolis, IN, 46256-1025, United States

    Description

    HDL-Cholesterol gen.3. For the quantitative determination of high-density lipoprotein Cholesterol (HDL-C) in serum and plasma.

    Reason

    Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

    Code Info

    Catalog Numbers: 05401470190; 03263991190; 05168589190; 03263991190.

    Distribution

    US (nationwide) including PR.

    Quantity

    6255 analytical units